Arrhythmogenic Right Ventricular Cardiomyopathy: Difference between revisions
Arrhythmogenic Right Ventricular Cardiomyopathy (view source)
Revision as of 11:53, 1 May 2008
, 1 May 2008no edit summary
mNo edit summary |
No edit summary |
||
| Line 43: | Line 43: | ||
'''Treatment''' focuses on avoiding complications.<cite>ACC2006</cite> | '''Treatment''' focuses on avoiding complications.<cite>ACC2006</cite> | ||
*Medication: | *Medication: | ||
**anti-arrithmics: Amiodarone | **anti-arrithmics: Sotalol better than Amiodarone. | ||
**ACE-inhibitors to prevent cardiac remodelling | **ACE-inhibitors to prevent cardiac remodelling | ||
*[[ICD]] implantation is recommended for the prevention of sudden cardiac death in patients with ARVC with documented sustained VT or VF who are receiving chronic optimal medical therapy. | *[[ICD]] implantation is recommended for the prevention of sudden cardiac death in patients with ARVC with documented sustained VT or VF who are receiving chronic optimal medical therapy. | ||